Compare BFC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFC | ARDX |
|---|---|---|
| Founded | 1894 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2018 | 2014 |
| Metric | BFC | ARDX |
|---|---|---|
| Price | $136.37 | $6.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $150.00 | $14.67 |
| AVG Volume (30 Days) | 75.9K | ★ 3.8M |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | ★ 11.23 | N/A |
| EPS | ★ 7.23 | N/A |
| Revenue | N/A | ★ $2,607,000.00 |
| Revenue This Year | $58.67 | $38.22 |
| Revenue Next Year | $2.01 | $33.85 |
| P/E Ratio | $18.87 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $93.00 | $3.50 |
| 52 Week High | $153.00 | $8.40 |
| Indicator | BFC | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 43.64 | 41.69 |
| Support Level | $118.71 | $5.49 |
| Resistance Level | $140.92 | $6.41 |
| Average True Range (ATR) | 4.21 | 0.37 |
| MACD | -1.20 | -0.04 |
| Stochastic Oscillator | 28.64 | 43.49 |
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.